Connect with us

We Speak Financials

Celine Dion’s Comeback Is a Money Machine: $125.5 Million Grossed in Just 16 Paris Shows

Published

on

Comebacks are usually measured in applause. Celine Dion’s is measured in box office. The first leg of her Paris residency grossed $125.5 million and sold 539,000 tickets across just 16 shows in September and October, according to Billboard Boxscore figures.

Break that down and it gets remarkable. The run averaged $7.8 million per night, more than ten times her per-night take from her Las Vegas residencies, and above the $6.1 million per show U2 averaged at the Sphere. Her average crowd of about 33,700 a night nearly doubled the next best residency draw, Billy Joel’s 18,600 at Madison Square Garden.

The context is what makes it a story. Dion’s Courage World Tour paused in March 2020 after grossing more than $100 million, and a planned return was cancelled in 2023 following her stiff-person syndrome diagnosis. Across her career she has now grossed $1.3 billion, sold 9.8 million tickets and played 1,517 concerts. Her two Las Vegas residencies alone grossed $385.1 million over 714 shows and $296.2 million over 427 dates.

She returns to Paris next May for 10 more shows, which are expected to push the residency’s totals even higher.

The money, in plain words: scarcity plus devotion is the most powerful pricing in live music. A legend who nearly lost the ability to perform, playing a limited run, is out-earning every residency act on Earth, per night, by a wide margin.

We Speak Financials

Tom Lee Called 7,700 by Christmas. The Market Got There in October, So He Moved His Target to 8,000

Published

on

Wall Street’s loudest bull just got his number early. Last December, Fundstrat strategist Tom Lee set a year-end 2026 target of 7,700 for the S&P 500, one of the most bullish calls on the Street at the time. On October 20, the index closed at 7,713, hitting Lee’s year-end number with more than two months to spare. Lee has since raised his target to 8,000.

To be clear on whose view this is: these are Lee’s calls, made publicly by Fundstrat, and we are reporting them the way we report any analyst’s call, with his name on them. They are not our recommendation, and this article is not financial advice.

The interesting part is the gap between the call and the product. Lee’s Granny Shots ETF, ticker GRNY, built around Fundstrat’s themes and holding 42 large-cap U.S. stocks, is up 10.4 percent this year. That trails the S&P 500’s 12.7 percent gain and the Nasdaq-100’s 16.8 percent, in the very year his headline call landed. In 2025 the fund returned 24 percent, ahead of the index’s 17.7 percent.

He is not alone in that gap. In the first half of 2026, 67 percent of U.S. large-cap funds did worse than the S&P 500 itself, according to the S&P Dow Jones Indices scorecard.

The money, in plain words: calling the market right and beating the market are two different skills. Lee nailed the first one this year. The second one is beating almost everybody, including, so far, him.

Continue Reading

Trending